Nilsson B O, Kockum I, Rosengren E
Department of Physiology and Neuroscience, University of Lund, Sweden.
Inflamm Res. 1996 Oct;45(10):513-8. doi: 10.1007/BF02311088.
In blood from the portal vein of anaesthetized rats the levels of histamine and putrescine were 2-3-fold lower compared to arterial blood. Putrescine concentration was increased severalfold and the difference between portal and arterial blood abolished in animals pretreated with the specific diamine oxidase inhibitor aminoguanidine. Histamine concentration was 40% lower in portal compared to arterial blood in animals treated with the mast cell degranulator compound 48/80. In animals pretreated with aminoguanidine, compound 48/80 enhanced the level of histamine and no difference was observed between arterial and portal blood. The amounts of intravenously injected [14C]-labeled histamine was about 15% lower in portal compared to arterial blood. The uptake of [14C]-putrescine from the small intestine was estimated. In urine from animals pretreated with aminoguanidine the concentration of [14C]-putrescine was more than 40-times higher than in control animals corresponding to a calculated uptake of about 7% in aminoguanidine treated animals. Our results suggest that intestinal diamine oxidase clears the blood from diamines and prevents luminal uptake of putrescine.
在麻醉大鼠门静脉血液中,组胺和腐胺水平比动脉血低2至3倍。在用特异性二胺氧化酶抑制剂氨基胍预处理的动物中,腐胺浓度增加了数倍,门静脉血与动脉血之间的差异消失。在用肥大细胞脱粒剂化合物48/80处理的动物中,门静脉血中的组胺浓度比动脉血低40%。在用氨基胍预处理的动物中,化合物48/80提高了组胺水平,动脉血和门静脉血之间未观察到差异。静脉注射的[14C]标记组胺量在门静脉血中比动脉血低约15%。估计了[14C]腐胺从小肠的摄取量。在用氨基胍预处理的动物尿液中,[14C]腐胺浓度比对照动物高40多倍,对应于氨基胍处理动物约7%的计算摄取量。我们的结果表明,肠道二胺氧化酶可清除血液中的二胺,并防止腐胺从肠腔摄取。